We use cookies to track visits to our website, and we don't store any of your personal details. Find out more

The Global Health Network The Global Health Network

Not a member?

Find out what The Global Health Network can do for you. Register now.

More

Less

Member Sites A network of members around the world. Join now.

Research Tools Resources designed to help you.

Publications

COVID-19 Vaccine Effectiveness project publications

1.    Jacobsen H, Sitaras I, Katzmarzyk M, Cobos Jiménez V, Naughton R, Higdon MM, Knoll MD. Waning of post-vaccination neutralizing antibody responses against SARS-CoV-2, a systematic literature review and meta-analysis. medRxiv. Epub 2023 Aug 8. doi: https://doi.org/10.1101/2023.08.08.23293864. (preprint, submitted to NPJ vaccines)

2.    Feikin DR, Higdon MM, Andrews N, Collie S, Deloria Knoll M, Kwong JC, Link-Gelles R, Pilishvili T, Patel MK. Assessing COVID-19 vaccine effectiveness against Omicron subvariants: Report from a meeting of the World Health Organization. Vaccine. 2023 Mar 31;41(14):2329-2338. doi: 10.1016/j.vaccine.2023.02.020. Epub 2023 Feb 9.

3.    Sitaras I, Jacobsen H, Higdon MM, Dowling WE, Bar-Zeev N, Deloria Knoll M. Systematic review of primary and booster COVID-19 sera neutralizing ability against SARS-CoV-2 omicron variant. NPJ Vaccines. 2022 Nov 15;7(1):147. doi: 10.1038/s41541-022-00565-y.

4.    Bobrovitz N, Ware H, Ma X, Li Z, Hosseini R, Cao C, Selemon A, Whelan M, Premji Z, Issa H, Cheng B, Abu Raddad LJ, Buckeridge DL, Van Kerkhove MD, Piechotta V, Higdon MM, Wilder-Smith A, Bergeri I, Feikin DR, Arora RK, Patel MK, Subissi L. Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression. Lancet Infect Dis. 2023 May;23(5):556-567. doi: 10.1016/S1473-3099(22)00801-5. Epub 2023 Jan 18.

5.    Jacobsen H, Katzmarzyk M, Higdon MM, Jiménez VC, Sitaras I, Bar-Zeev N, Knoll MD. Post-Vaccination Neutralization Responses to Omicron Sub-Variants. Vaccines (Basel). 2022 Oct 20;10(10):1757. doi: 10.3390/vaccines10101757.

6.    Higdon MM, Baidya A, Walter KK, Patel MK, Issa H, Espié E, Feikin DR, Knoll MD. Duration of effectiveness of vaccination against COVID-19 caused by the omicron variant. Lancet Infect Dis. 2022 Aug;22(8):1114-1116. doi: 10.1016/S1473-3099(22)00409-1. Epub 2022 Jun 22.

7.    Jacobsen H, Cobos Jiménez V, Sitaras I, Bar-Zeev N, Čičin-Šain L, Higdon MM, Deloria-Knoll M. Post-vaccination T cell immunity to omicron. Front Immunol. 2022 Jul 26;13:944713. doi: 10.3389/fimmu.2022.944713.

8.    Feikin DR, Abu-Raddad LJ, Andrews N, Davies MA, Higdon MM, Orenstein WA, Patel MK. Assessing vaccine effectiveness against severe COVID-19 disease caused by omicron variant. Report from a meeting of the World Health Organization. Vaccine. 2022 Jun 9;40(26):3516-3527. doi: 10.1016/j.vaccine.2022.04.069. Epub 2022 May 2.

9.    Jacobsen H, Sitaras I, Jurgensmeyer M, Mulders MN, Goldblatt D, Feikin DR, Bar-Zeev N, Higdon MM, Knoll MD. Assessing the Reliability of SARS-CoV-2 Neutralization Studies That Use Post-Vaccination Sera. Vaccines (Basel). 2022 May 26;10(6):850. doi: 10.3390/vaccines10060850.

10.    Higdon MM, Wahl B, Jones CB, Rosen JG, Truelove SA, Baidya A, Nande AA, ShamaeiZadeh PA, Walter KK, Feikin DR, Patel MK, Deloria Knoll M, Hill AL. A Systematic Review of Coronavirus Disease 2019 Vaccine Efficacy and Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Disease. Open Forum Infect Dis. 2022 Apr 18;9(6):ofac138. doi: 10.1093/ofid/ofac138.

11.    Feikin DR, Higdon MM, Abu-Raddad LJ, Andrews N, Araos R, Goldberg Y, Groome MJ, Huppert A, O'Brien KL, Smith PG, Wilder-Smith A, Zeger S, Deloria Knoll M, Patel MK. Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression. Lancet. 2022 Mar 5;399(10328):924-944. doi: 10.1016/S0140-6736(22)00152-0. Epub 2022 Feb 23.

COVID-19 Vaccine Safety project publication

ShamaeiZadeh PA, Jaimes CV, Deloria Knoll M, Espié E, Chandler RE. Landscape review of active vaccine safety surveillance activities for COVID-19 vaccines globally; Vaccine: X 2024;18. doi: 10.1016/j.jvacx.2024.100485.